Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TRND (The Rare Network) is a healthcare technology company focused on accelerating the development of treatments for rare diseases through a specialized data and community platform. The company leverages advanced analytics and a global network of patients, researchers, and clinicians to generate real-world evidence and facilitate clinical trial recruitment. By bridging the gap between rare disease communities and the pharmaceutical industry, TRND aims to reduce the time and cost associated with orphan drug development. Their services include patient identification, natural history studies, and strategic consulting for biotech firms navigating the rare disease landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TRND.